Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
University of Tennessee
University of Tennessee
University of Birmingham
Alliance for Clinical Trials in Oncology
Center for International Blood and Marrow Transplant Research
University of Kansas Medical Center
Korea Otsuka Pharmaceutical Co., Ltd.
Shenzhen Second People's Hospital
Weprom
Gruppo Italiano Malattie EMatologiche dell'Adulto
Gruppo Italiano Malattie EMatologiche dell'Adulto
Gruppo Italiano Malattie EMatologiche dell'Adulto
Nanfang Hospital, Southern Medical University
Grupo Cooperativo de HemopatÃas Malignas
Nanfang Hospital, Southern Medical University
Assiut University
Associazione Italiana Pazienti Leucemia Mieloide Cronica
University Health Network, Toronto
National Research Center for Hematology, Russia
Ministry of Health, Malaysia
Fusion Pharma LLC
M.D. Anderson Cancer Center
University Health Network, Toronto
Seoul St. Mary's Hospital
Assiut University
Ankara University
Fundación Teófilo Hernando, Spain
Command Hospital, India
Hospital de Clinicas de Porto Alegre
The University of Hong Kong
Gruppo Italiano Malattie EMatologiche dell'Adulto
First Affiliated Hospital of Harbin Medical University
Versailles Hospital
HaEmek Medical Center, Israel
Institut Bergonié
Assiut University
The University of Hong Kong
Hospital Universitario Dr. Jose E. Gonzalez
University of Bonn
Seoul St. Mary's Hospital
Centre Hospitalier Universitaire de Nice
Nanfang Hospital, Southern Medical University
Ulsan University Hospital
Ulsan University Hospital
Tongji Hospital
PETHEMA Foundation
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Samsung Medical Center
Cttq
University of Erlangen-Nürnberg Medical School
Seoul St. Mary's Hospital